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Abstract 
Cardiovascular disease (CVD) is increasingly becoming one of the largest contributors 
to preventable death globally each year.  This disease is predominately caused by poor 
lifestyle choices such as unhealthy diet, inactivity, smoking and the harmful use of 
alcohol.  Modern treatments of CVD are often surgical and pharmaceutical which can be 
both invasive and expensive and do not necessarily address the causation or 
prevention of the disease. Research is now being done in preventative health to study 
the effects that a healthy lifestyle has in both reducing and even reversing CVD.  
Lifestyle intervention programs are a part of this preventative health phenomenon.  This 
study aims to explore the nature and effectiveness of the Coronary Health Improvement 
Program (CHIP), in its ability to reduce CVD risk factors.    
Data was collected from a set of volunteer-delivered CHIP programs that were 
conducted in Hawera, New Zealand.  The sample consisted of 284 participants who 
responded voluntarily to local program advertising.  Participants were given a blood 
screening and questionnaire which was conducted at the commencement and 
conclusion of the 30 day intervention.  The blood screening was given to measure 
baseline biometrics (BMI, total cholesterol, low density lipoprotein, high density 
lipoprotein, triglycerides and glucose) and the questionnaire was a tool used to gather 
information about the participants’ basic demographics, lifestyle, and family and medical 
histories.  The data was then analysed to determine changes in the blood screening 
biometrics post intervention.  Also these changes were further examined to determine 
the impact, if any, of participants’ lifestyle and family medical histories.  An analysis of 
the nature of the program and its delivery was also conducted through interviews with 
the program facilitator. 
Participants’ blood screening results post intervention indicated a significant reduction in 
their biometrics from the baseline scores with reductions of 4% to 23%. In particular, 
participants who recorded high baseline figures recorded the most significant changes 
after the 30 days.  There were significant differences across gender, marital status and 
age in the reduction of a number of the participants’ biometrics. 
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This study provides valuable evidence suggesting that a volunteer-delivered, community 
based, CHIP lifestyle education program is effective in improving the health of 
participants and, in particular, reducing CVD risk factors.  These findings will be 
important for the designing and delivery of lifestyle education programs for the 
prevention and treatment of CVD for the future. 
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Chapter One 
Rationale 
The World Health Organization states that 63% of all global deaths in 2008 were a 
result of non-communicable diseases (WHO, 2008).  More specifically, 36 million out of 
a total of 57 million deaths globally in 2008 were attributed to lifestyle diseases.  The 
four biggest killers were cardiovascular disease, cancer, respiratory diseases and 
diabetes.  These diseases mainly occur as a result of poor lifestyle choices, in particular 
tobacco use, physical inactivity, unhealthy diet, and the harmful use of alcohol.  It is 
clearly evident that lifestyle disease is becoming a huge problem.  Up until recently the 
current paradigms for management of these diseases have been surgical and 
pharmaceutical.  This type of management is putting enormous pressure on the health 
care systems.  However the emergence of lifestyle medicine and prevention is 
becoming increasingly widespread.   
 
Lifestyle education programs are being developed in response to the emerging research 
being done in this area of preventative health.  Two programs in particular are currently 
operating with great success in reducing CVD.  They are the Pritikin Longevity Centre 
and the Ornish Lifestyle Centre.   Whilst the Pritikin and Ornish residential education 
programs have proven to be effective in improving health for patients, they are very 
costly and often inaccessible to some people who, for whatever reason, are unable to 
stay in a residential facility.  Another program, the Coronary Health Improvement 
Program (CHIP) has demonstrated significant reductions in cardiovascular risk factors 
(Englert et al. 2007). Whilst this program was initially designed by Dr. Hans Diehl for 
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people with coronary health issues, the program is being delivered to participants in 
view to improve all aspects of health. The CHIP program aims to educate participants 
on making lifestyle changes that involves a diet which is whole plant food based, with 
little or no animal products. As well as modifying their nutrition, it also recommends 
participants engage in at least 30 minutes of daily exercise. Identifying and 
implementing ways to reduce stress and cease smoking is also part of the programs 
guidelines for holistic health.   
A volunteer delivered CHIP lifestyle education program mentioned above, has been 
functioning in America for a number of years.  It is a low cost and easily accessible 
alternative to the residential based programs.  A study of the results of these programs 
was conducted with up to 4500 participants.  These participants overall recorded 
significant changes to their biometrics.  The two most significant changes included an 
11% decrease in total cholesterol and a 13% decrease in low density lipoprotein post 
intervention. Analysis of this data from these CHIP programs indicated that this program 
was effective in reducing cardiovascular risk factors (Rankin et al. 2012). 
 
Whilst this study was conducted in an American context, no studies have determined 
the effectiveness of the CHIP program within a New Zealand setting. Therefore, there is 
a need to explore the effectiveness of the CHIP program in reducing CVD risk factors in 
a New Zealand context.  Further analysis of the nature of the delivery of this education 
program is also required.   
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This case study aims to meet this need by accessing data from a series of volunteer 
delivered CHIP programs that have taken place in the city of Hawera, New Zealand.   
 
Research Question 
This study is directed by the following research questions: 
1) What are the key components of the volunteer delivered CHIP lifestyle education 
program with reference to Hawera based programs? 
2) How effective were the CHIP programs conducted in Hawera in reducing CVD risk 
factors of the participants? And further, what impact does participants 
demographics, previous lifestyle patterns and initial health conditions have on these 
outcomes? 
Structure of the Thesis 
This thesis consists of six chapters and is presented in the following manner.  Chapter 
one focuses on the purpose, rationale and aims for this study. It also identifies the 
questions that the study attempts to answer.  Chapter Two will discuss the relevant 
literature relating to lifestyle education programs.  Chapter Three identifies the 
methodologies chosen, including information on the sample and data analysis 
processes.  Chapter Four will explore the nature of the program including program 
delivery, team membership, advertising and community response.  Chapter 5 discusses 
the results in terms of overall data and specific analysis of biometrics categories.  The 
final chapter discusses the results outlined previously as well as identifying any 
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limitations and implications for future studies.  
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Chapter Two 
Literature Review 
Introduction 
Studies being done in the area of preventative health indicate poor lifestyle choices are 
causing major diseases in individuals. One such article states that the world is feeling 
the impact of a global chronic disease epidemic which it terms “diseases of comfort” 
cause by poor lifestyle choices.  (Choi et al., 2005) 
Cardiovascular disease is one of these diseases that is responsible for millions of 
deaths globally each year and yet it is largely preventable through lifestyle change.   It is 
important to therefore identify risk factors for cardiovascular disease and the lifestyle 
changes that can be made to reduce and even reverse this killer.   
 
Cardiovascular Disease 
Cardiovascular disease (CVD) refers to diseases relating to the heart or blood vessels. 
The World Health Organisation (WHO) report, published in September 2011, states that 
CVDs are the leading cause of death and disability in the world.   These statistics are 
quite concerning, especially considering that many forms of CVDs are preventable 
through simple lifestyle changes.  The Framingham study which commenced in 1948 
was the first study which identified the major risk factors for CVD.  This study indicated 
that cigarette smoke, increased cholesterol levels, elevated blood pressure, obesity and 
inactivity were the major risk factors associated with CVD (O’Donnell & Elosua, 2008).  
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Since then, many studies have been done to identify the various risk and biometric 
factors which contribute to CVD.  As previously identified indicated tobacco use, 
physical inactivity, unhealthy diet and harmful use of alcohol are the main risk factors to 
these diseases (WHO, 2008). The INTERHEART study which was completed in 2004 
and involved over 52 countries identified diabetes, hypertension, psychological factors 
and a lack of consumption of fruit and vegetables as additional risk factors for CVD. 
(Yusuf et al., 2004) These risk factors can be grouped into two categories; lifestyle 
habits and biometric risk factors.   The lifestyle related risk factors include; smoking, 
diet, inactivity and mental health, whilst the biometric risk factors include cholesterol, 
blood pressure, obesity and diabetes.   
 
Lifestyle Related Risk Factors 
Smoking 
A study by Ambrose and Barua (2004) into the pathophysiology of cigarette smoking 
and CVD identified that smoking in any form contributes to cardiovascular morbidity and 
mortality. Burns (2003) attributes some 140,000 premature deaths that occur each year 
to CVD from smoking.  The effect of smoking on the cardiovascular system is clear and 
studies have found that cigarette smoking predisposes the individual to several different 
cardiovascular effects including; angina, acute coronary syndromes, sudden death and 
stroke. (Ambrose & Barua 2004)  Interestingly however the damage to the 
cardiovascular system from smoking also relates to those who are exposed to cigarette 
smoke through passive environmental smoking.  Taylor, Johnson and Kazemi (1992) 
identify the effects of environmental tobacco smoke as affecting cardiovascular function, 
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platelet function, neutrophil function and plaque formation which are all probable factors 
leading to heart disease. Benowitz (2009) identifies that cessation of smoking at any 
age can dramatically reduce these risks associated with smoking.  However he goes on 
to say that quitting is often difficult given the addictive nature of tobacco.   
 
Diet 
Reddy (2010) identifies that diet, and the nutrients that are consumed, are major 
determinants which can initiate and influence the course of cardiovascular disease.   A 
poor dietary intake is related to a number of cardiovascular risk factors which can 
include; hypertension, abnormal blood lipids and abdominal obesity (Yusef et al., 2004).  
A cohort of studies done on nutrition and cardiovascular disease showed that a diet 
consisted primarily of a high consumption of plant based foods (such as fruits, 
vegetables, nuts and whole grains) was associated with significantly lower incidences of 
coronary artery disease and stroke (Hu, 2003).  
 
Physical Inactivity 
An article written for the Cancer Journal for Clinicians (Eyre et al., 2004) argues that 
there is evidence to suggest that physical activity reduces chronic disease risk both 
directly in its impact on hormone levels and indirectly through its impact on weight 
control.  A statement from the Council on Clinical Cardiology (Subcommittee on 
Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, 
and Metabolism (Subcommittee on Physical Activity) identified that habitual physical 
activity not only can prevent the development of coronary artery disease but also reduce 
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the symptoms in patients who already have established coronary disease. In a study 
conducted by Blair (2001) the greatest cardiovascular disease benefits were obtained 
by those who exercised vigorously.   
 
Mental Health 
Whilst smoking, diet and physical activity are more commonly known risk factors for 
cardiovascular disease, psychological factors are also contributors. In a study by Ford 
and colleagues (1998), it was revealed that clinical depression was in fact an 
independent risk factor for coronary heart disease.  Yusuf (2004) also identified other 
psychological factors such as prolonged stress and anxiety (which can lead to a state of 
disequilibrium) over time can result in heart disease.  Katon Lin & Kroenke (2007), in 
analysing the results of 31 studies with 16922, patients identify that depression and 
anxiety can be strongly associated with cardiovascular disease and other chronic 
medical diseases.   
 
Biometric Risk Factors 
Cholesterol 
Whilst cholesterol is important for normal body function, elevated cholesterol levels are 
strongly linked with cardiovascular diseases (Krauss et al., 2000).  Total cholesterol is 
made up of low density lipoproteins (LDL) and high density lipoproteins (HDL).  HDL is 
considered to be very important for good health as it takes cholesterol away from the 
cells and tissues and to the liver for excretion.  The function of LDL is to take cholesterol 
to the places it is required in the body.  High levels of LDL however can result in a build-
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up of cholesterol and cause hardening of artery walls leading to cardiovascular 
diseases.  Studies have found that a reduction in the level of LDL in the body can 
decrease the risk of a cardiac event (Assmann, G, 1998: Wilson, Anderson, Castelli & 
Kannel, 1991).  It has also been suggested that an increase in HDL levels can decrease 
the risk of a cardiac event (Brown et al., 2001).  
 
Blood Pressure 
High blood pressure is associated with an increased risk of cardiovascular disease 
(Vasan et al., 2001).  This risk factor increases as blood pressure reaches above 
normal range, i.e. <120 systolic and <80mmHG diastolic. (Stamler, Stamler & Neaton, 
1993).   A study done to determine the impact of high normal blood pressure on 
cardiovascular disease found that those with high normal blood pressure had an 
increased risk of disease by 2.5% amoung women and 1.5% amoung men (Vasan et 
al., 2001).  Studies have concluded that adopting a healthy lifestyle eating plan and 
reducing sodium consumption can lower blood pressure substantially (Sacks et al., 
2001). 
 
Obesity 
Sowers (1998) identifies obesity as a risk factor for cardiovascular disease.  He found 
that obesity can often lead to diseases such as diabetes and hypertension which can, in 
turn, further contribute to the risk of cardiac disease.  Obesity is a metabolic disorder.  
The excess fat stored by the body in various places can in fact increase risk of coronary 
artery diseases such as dyslipidemia, hypertension, glucose intolerance, inflammatory 
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markers, and the prothrombotic state (Poirier & Eckel, 2000). The results of a study to 
identify the impact excess body weight had on CVD found that the increase in excess 
body weight of individuals increased the prevalence of cardiovascular disease.  For 
individuals with a normal weight the prevalence of CVD was 20%, for overweight 
individuals the rate increased to 28% and in obese individuals, 29% (Wang et al., 2002). 
 
Diabetes  
Diabetes is considered to be one of the major risk factors of CVD (Grundy et al., 1999).  
One study identifies CVD as the cause of death for 65% of people with diabetes 
(Gieuss, 1995).  Individuals with type 2 diabetes are at a greater risk of cardiac disease 
due to the likelihood of developing hyperglycemia, hypertension, and dyslipidemia 
(Gaede et al., 2003).  
 
Lifestyle Medicine:  Key Players  
Dean Ornish 
Dr Dean Ornish is well known as one of the founders of preventative health. In 1977, Dr 
Ornish discovered through research that lifestyle changes could stop and reverse 
coronary heart disease and many other chronic diseases.  These lifestyle changes 
included eating a whole foods plant based diet, engaging in moderate exercise, ceasing 
smoking and using stress management techniques such as yoga and meditation as well 
as having psychosocial support (Ornish Spectrum, 2012). He and his colleagues 
developed a program called ‘Dr Ornish’s Program For Reversing Heart Disease’ which 
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targets four basic lifestyle elements; what you eat, how much activity you have, how you 
respond to stress and how much love and support you have.  (Ornish Spectrum, 2012) 
Dr Ornish outlines below the important role that lifestyle plays in individual health and 
wellbeing.  
 “People often think that advances in medicine have to be a new drug, a new laser, or a 
 surgical intervention to be powerful—something really high-tech and expensive. They 
 often have a hard time believing that the simple choices that we make in our lives 
 each day—what we eat, how we respond to stress, whether or not we smoke, how much 
 we exercise and the quality of our relationships—can make such a powerful difference in 
 our health, our well-being, and our survival, but they often do” (Ornish Spectrum, 2012). 
Caldwell Esselstyn 
In 2007, Dr Esselstyn (who is an internationally known surgeon, researcher and clinician 
at the Cleveland Clinic) wrote the book entitled; Prevent and Reverse Heart Disease.  
He identified that patients who were treated surgically or pharmaceutically to reduce the 
impact of symptoms but little preventative treatment was prescribed.  After analysing the 
results on a 20 year study on nutrition, Dr Esselstyn advocated that a strict vegan diet 
can prevent and reverse heart disease.  Dr Esselstyn outlines his idea of medicine as 
being more than just surgical.   
 "Beyond surgery" does not mean one must relinquish the cherished burden of 
 operative responsibility, but it does imply that we must participate in the endeavor 
 to eliminate and prevent diseases by nonsurgical methods of lifestyle changes  
 (Esselstyn, 1991). 
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Lifestyle Education Programs 
Lifestyle education programs are being developed in response to the emerging research 
being done in the area of preventative health.  Two programs in particular are currently 
operating with great success in this area.  They are the Pritikin Longevity Centre and 
the Ornish Lifestyle Centre.    
 
Pritikin Longevity Centre 
The Pritikin Longevity Centre was developed in the early 1980 by Nathan Pritikin.  He 
initially designed a 3 week residential lifestyle program.  His program targets three main 
areas; nutrition, exercise and mind body health.  The nutrition involves eating minimally 
processed plant foods such as fruits, vegetables and whole grains, as well as modest 
amounts of non-fat dairy, soy and fish.  Eating these types of foods as well as taking 
regular exercise and minimising stress is the key message of the Pritikin Longevity 
Centre.  A study which was conducted on 4587 participants of the program recorded a 
23% decrease in total cholesterol, 33% decrease in trigylcerides, and 23% decrease in 
LDL cholesterol (Barnard, 1991). 
 
Ornish Lifestyle Centre 
As mentioned previously Dean Ornish developed a program that is aimed at targeting 
lifestyle changes.  This program divides all foods into a spectrum of choices.  These 
range from those choices which are very healthful (fruits, vegetables, grains) to those 
which are least healthful (cakes, fried foods).  However, with regards to reversing heart 
disease specifically, Ornish has identified some specific guidelines including; limiting fat 
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intake to no more than 10%, a cessation of animal products except non-fat dairy 
products, limiting sugar intake, a cessation of caffeine and limiting alcohol consumption. 
Several studies have been done on this program to ascertain its effectiveness in 
reversing heart disease. One particular study conducted with 48 patients (20 patients 
were the control and the other 28 completed the lifestyle intervention program) indicated 
a decrease in low density lipoprotein (LDL) of 37.2% compared with the control group of 
1.2% after just one year. Also patients involved with the lifestyle changes recorded 
fewer cardiac events in the 5 years post the intervention (Ornish et al., 1990). 
 
CHIP Program 
Whilst the Pritikin and Ornish residential education programs have proven to be 
effective in improving health for patients, they are very costly and often inaccessible to 
people who are unable to stay in a residential facility, due to commitments such as 
family and work.  A lifestyle education program which is run in the community has 
proven to be a low cost and easily accessible program for people wanting to improve 
their health and lifestyle.  The Coronary Health Improvement Program (CHIP) has 
demonstrated significant reductions in biometric risk factors (Englert et al. 2007). 
 
Whilst other lifestyle intervention programs are professionally delivered, the CHIP 
program has been designed to be delivered by a team of volunteers.   These volunteers 
participate in a weekend training program and are accredited to deliver the CHIP 
program in their respective communities.  The expertise is not provided by the leaders 
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of the program but rather through the viewing of the DVDs presented by the developer 
of the program.   
 
This intensive education program involves participants attending sixteen, 2 hour 
sessions over a period of four to five weeks.  These sessions aim to provide participants 
with the knowledge and ability to make lifestyle changes to improve their health.  The 
educational pre-recorded lectures which are presented by Dr Hans Diehl, inform 
participants about the causation of diseases and how lifestyle changes can prevent and 
reduce these health concerns.  
 
There have been over 20 articles on CHIP which have been published to date.  A 2007 
article, analysed data from over 1500 participants in five CHIP programs conducted in 
Rockford, Illinios.   The results indicated highly significant reductions in participants’ 
total cholesterol, LDL, triglycerides, blood glucose and blood pressure (Englert et al., 
2007). This article concluded that a well-designed community based education program 
is effective in improving health for participants. (Englert et al., 2007) 
 
One of the more recent articles which involved over 5000 CHIP participants similarly 
demonstrated significant reductions in the participants’ body mass, blood pressure, total 
cholesterol, low density lipoprotein, triglycerides and fasting plasma glucose.  Of these 
participants, those who were considered most at risk recorded the greatest 
improvements to their health (Rankin et al., 2011). 
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It is evident that cardiovascular disease is a major problem and burden today.  The 
biometric and risk factors pertaining to these diseases have been well identified.  
Lifestyle education programs such as CHIP have proven to be effective in achieving 
positive changes to participant’s lifestyle through reductions of those risk factors.  The 
CHIP program, comparative to other intervention programs, is very effective with its low 
cost, high accessibility and volunteer delivery.   
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Chapter Three 
Methodology 
Introduction 
This chapter presents a rationale and description of the research orientation used in the 
study.  This study looks at the effectiveness of a volunteer delivered lifestyle education 
program in reducing risk factors associated with cardiovascular disease.  Limited 
research has been conducted to ascertain the effectiveness of volunteer based delivery 
of lifestyle education programs.  But such studies have been based in the United States 
and have accessed data from a number of delivery sites.  The aim of this study is to 
evaluate the effectiveness of a New Zealand based, volunteer-delivered program 
conducted from a single site.  To fulfil this aim, the research adopted a case study 
approach, which was observational quasi-experimental and quantitative in its 
orientation.   
This study will explore the changes in participants’ biometrics risk factors (total 
cholesterol, low density lipoprotein, high density lipoprotein, triglycerides and fasting 
plasma glucose, BMI and blood pressure) pre and post involvement in a 30 day CHIP 
program (refer to Chap 4).  The biometric and demographic data taken from the CHIP 
survey instrument and blood screening results recorded by the program co-ordinators 
and will be accessed by the researcher.  Participants consented to have their data 
collected and used for research purposes.  Access to the data was obtained with the 
permission from the Lifestyle Medicine Institute (New Zealand). 
17 
 
 
Sample 
Data will be sourced for this case study from seven programs run independently by 
group leader Dr T in Hawera, NZ.   Participation in the CHIP program is voluntary and is 
as a response to formal and informal advertising conducted by the local CHIP team.  
Each program was run under the leadership of Dr T and around five core support 
personnel.  Hawera is a rural town with a population of approximately 11,000 people 
situated in dairy farming province of Taranaki.   
 
Quantitative Measures 
From the CHIP survey and blood screening process the demographic, biometric, 
lifestyle habits, family story and medical history statistics will be determined.  
 
Demographic Measures 
Through the survey instrument, data will be collected relating to the participants general 
demographic features of age, gender, marital status and religious affiliation.   
 
Biometric Measures 
Data will be obtained from blood samples collected from participants at the 
commencement and conclusion of the CHIP program and sent to the pathology 
laboratories for biometric analysis.  This blood screening will include measures for total 
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cholesterol, high density lipoprotein, low density lipoprotein, triglycerides, and fasting 
blood glucose levels.   
 
Other biometric measures that will be collected from the CHIP survey include: height, 
weight and waist circumference.  From this data the participants Body Mass Index (BMI) 
will be calculated and recorded. Along with this the participants will have their systolic 
and diastolic blood pressure taken pre and post intervention. 
For each of the biometric measures identified, participants will be placed in respective 
risk factor classification groupings.   
Biometric Risk Factor Classifications 
The National Cholesterol Education Program Adult Treatment Panel III classification 
system 7 will be used to categorise participants for all risk factors excluding total 
cholesterol (National Cholesterol Education Program, 2002). The Framingham 
classification will be used for the stratification of the total cholesterol data (Wilson et al., 
1998).  This classification identified five categories of cholesterol levels which allows for 
a more detailed analysis to be made of the effects of the intervention for the highest risk 
participants than the National Cholesterol Education Program Adult Treatment Panel III 
classification system 7. 
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Lifestyle Measures 
Data will be obtained from the CHIP survey questions relating to specific lifestyle habits 
such as exercise levels and smoking status both before and after the CHIP program to 
determine lifestyle measures. 
 
Family and Medical History Measures 
Data will be obtained from the CHIP survey questions relating to the participants’ health 
history and family history of cardiovascular disease and diabetes, in order to generate 
family and medical history measures.  In particular their histories of asthma, diabetes 
and cardiac events will be accessed.    
 
Data Analysis 
The data from the CHIP survey and blood screening will be entered into the statistical 
software package SPSS 17.0 (SPSS 17.0 for Windows, SPSS Inc).  Descriptive 
statistics for each measure and sub measure will be determined.  Dependent and 
Independent group t-tests and independent one way between groups ANOVA with post-
hoc comparisons will be run to locate any area of significant difference between 
participant group or subgroup measures. Cohen’s d will be calculated to determine the 
effect size of the CHIP intervention with respect to each of the measured biometrics for 
participant groups and sub groups. 
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Chapter Four 
The CHIP Program 
Elements Of The Program 
CHIP stands for Coronary Health Improvement Program, but it involves much more than 
the name suggests.  Whilst the program was initially designed by Dr. Hans Diehl for 
people with coronary health issues, the program is being delivered to participants in 
view to improve all aspects of health. CHIP aims to educate participants on making 
lifestyle changes that involve a diet which is whole plant food based, with little or no 
animal products. As well as modifying their nutrition, it also recommends participants 
engage in at least 30 minutes of daily exercise. Identifying and implementing ways to 
reduce stress and ceasing smoking is also part of the programs guidelines for holistic 
health.   
Participants begin the program by fasting for 8 hours and undergoing a blood screening.  
The blood sample is sent away to be analysed for cholesterol levels, (HDL, triglycerides, 
total cholesterol and LDL) and fasting plasma glucose levels.  The participants are also 
weighed, their height is measured, their blood pressure tested and they have their 
resting pulse recorded for further evaluative tests such as body mass index (BMI).  
Participants are also required to complete a questionnaire which asks questions about 
dietary and exercise habits, their past exposure/histories of smoking, obesity, diabetes, 
high blood pressure, and cardiac events as well as common questions about age, 
gender and religious affiliation.  Another aspect of the questionnaire involves collecting 
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information on the attendee’s family history of diabetes, cancer and coronary health.  
This process is then repeated post-intervention to measure the participants’ progress.  
Once the preliminary testing is completed, the face to face meetings commence.  The 
program consists of approximately 40 hours of face to face meetings conducted over a 
period of 16 sessions, usually within a four or five week period of time.  Each meeting 
includes the viewing of a DVD, a cooking demonstration and a group discussion.  Whilst 
the meeting does not include an exercise component, participants are encouraged each 
session with tips on how to exercise. One of the meetings also includes a shopping tour 
where participants are shown how to make informed and effective dietary choices using 
produce and groceries from their local supermarket.   
The topics covered in the DVD viewing time and group discussion include: 
• modern medicine: its accomplishments and limitations 
• atherosclerosis 
• coronary risk factors 
• smoking 
• exercise 
• dietary fibre 
• cholesterol 
• the optimal diet 
• obesity 
• diabetes 
• hypertension 
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• hyperlipidaemia 
• lifestyle and health 
• behavioural change 
• self-worth (Englert, Diehl et al., 2004) 
After the program is completed participants are given their final blood screening and 
questionnaire and are encouraged to join the CHIP Alumnus which meets once a month 
to keep participants informed and encouraged on maintaining their healthy lifestyle 
choices.   
 
Delivery 
CHIP was designed to be conducted in a non- medical environment, delivered by 
volunteer directors.  This is made possible by supplying the directors with the DVD’s 
which contain all the information presentations.  This provides the essential information 
needed for the team leaders to pass onto the participants at the meetings. In order to 
equip these volunteer directors with the necessary tools to effectively conduct a CHIP 
program, each volunteer is required to complete an intensive weekend of training.  At 
this training weekend volunteer directors are given materials and attend workshops 
which teach them the skills necessary to deliver the CHIP program in their local area.   
  
23 
 
Hawera Based CHIP Program 
Dr T is the facilitator for the CHIP programs that were conducted in Hawera.   The data 
collected from these programs forms the basis for this case study.  Dr T is a General 
Practitioner who is passionate about preventative health. He completed training to be a 
leader for the CHIP program at a weekend CHIP summit at the Gold Coast, Australia.  
He has since conducted 7 CHIP programs in Hawera.   
 
Team 
There were a core team of helpers who assisted Dr T in delivering the CHIP program in 
Hawera.  The team for each program was different but was made up of approximately 5 
core members and extra volunteers.  These members were assigned various jobs, 
including welcoming, data collection, kitchen help and technical support.  Dr T was the 
main presenter for each program.  After the initial program was conducted, some 
participants from that program volunteered to support Dr T in facilitating other programs.   
 
Program Delivery 
The number of participants for each of the seven programs varied from 15 to 100 
participants.  Dr T suggested that the smaller groups were more effective in achieving 
group based discussion and more individualised attention for participants.  There have 
been over 300 people who have completed the CHIP program in the Hawera area 
under his direction.  The standard program delivery of 16 sessions in a 4 week period 
was extended with additional meetings once a week for a further 8 weeks before the 
graduation.  This was done with the intention to support participants more in their 
24 
 
lifestyle changes.   The program delivery for the meetings included cooking 
demonstrations and the viewing of the DVD and workbook materials that were supplied.  
The cost for participants was $440 for couples and for singles $300.   Participants were 
given an option to pay a deposit and then pay the remainder of the fee in weekly 
instalments.   
 
Data Collection 
The data from the questionnaires and blood tests was collected and entered into the 
CHIP assistant computer program by Dr T and his wife.   
 
Advertising 
There were many different mediums of advertising used to promote CHIP in Hawera.  
Pamphlets which were designed by Dr T were placed in strategic places such as 
hospitals, doctor’s surgeries and noticeboards.  Dr T visited the local Lions and Rotary 
clubs and gave short presentations on CHIP to encourage support and awareness of 
the program.  Newspaper and radio advertisements were also used.  Some patients of 
Dr T were also encouraged to attend the CHIP meetings and were sent information 
regarding upcoming programs in the area.  He estimated about 50% of all participants 
that attended the programs in Hawera were patients in his surgery.  Dr T commented 
that the best medium of advertising was word of mouth from previous CHIP participants. 
He said that word of mouth along with the newspaper advertisements were the most 
beneficial in bringing participants to the program.    
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Community Response 
Dr T indicated that the community response towards the program had been very 
positive.  A visit from Dr Hans Diehl, the creator of the program was very effective in 
generating interest in Hawera about CHIP.  In addition, the local newspaper had written 
a feature article in the weekend edition which also generated a good response from the 
community.   
Strengths and Weaknesses 
Upon reflection of the CHIP programs, DR T, identified two main weaknesses which 
required further attention. Firstly, the duration of each nightly meeting needed to be 
shortened.  The guidelines for running a CHIP program indicate the evening sessions to 
run for two and half hours however Dr T identified this as being too long for the 
participants and therefore adjusted it accordingly.   The meetings each night were 
reduced to one and a half hour sessions.  Another difficulty that was identified was in 
relation to the entry of data from the participants.  Dr Hurlow found that the CHIP 
assistant computer program was not user friendly and there were therefore many 
difficulties experienced in entering the data.  He concluded that a review of this program 
needed to be conducted to prevent future complications.  Despite these small setbacks, 
he found the programs to be an extremely positive event for the community.   
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The Educational Orientation of The CHIP Program 
There are many elements that contribute towards the success or failure of an education 
program.  The participants’ ability to acquire knowledge and skills, make behaviour 
changes where applicable and achieve measurable results are just some of the 
important elements that are required. The CHIP program conducted by Dr T and his 
team in Hawera involved the following key elements. 
 
Motivation 
Participants in this program were self-selected through an individual response to various 
advertising mediums.  The fact the people from the community chose to participate in 
this program indicates a high level of motivation in achieving personal goals.  This 
motivation is a key factor in the success of the program.  
 
Reputable Leadership 
The CHIP program was conducted by a local family medical practitioner.  His rapport 
within the community for the work he does in his general practise, as well as being a 
medical doctor, contributed to the effectiveness of the program.  In general, participants 
respond well when they have trust in the knowledge and skills of the leadership and the 
team. 
 
CHIP Support Team 
Some of the members of the community who had previously completed the CHIP 
program subsequently chose to become involved in the delivery of the new programs.  
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These previous participants were an invaluable resource as they encouraged the new 
group just beginning their journey.  All of the team members, including the group 
facilitator, volunteered their time and effort into conducting these programs.  One of the 
many benefits of this volunteer based delivery is the passion that leaders have in 
educating the community to live healthier lives.  Participants may find it easier to 
approach the team leaders and ask questions because they know they are volunteering 
their time and are therefore willing to help.   
 
Practical Skills 
As well as delivering information and knowledge to participants, this program aimed to 
provide practical applications through cooking demonstrations and tastings.  This 
process enabled participants to see how to prepare healthy foods for themselves and 
their families.   One of the meetings involved a trip to the local supermarket to show 
participants how to source local produce and products that are healthy.  In addition, they 
were given recipe books as part of their CHIP literature and the leadership team 
demonstrated recipes from this book at each meeting.  These simple lessons provided 
opportunities for participants to gain the skill sets required in sourcing and producing 
healthy food. 
 
Literature 
Participants were given a workbook, as well as other materials, that they could use to 
gather more information.  The workbooks provided a written way to apply their 
knowledge by answering questions and engaging in group dialogue with the responses.  
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This technique can provide enriched learning experiences for participants as they 
contribute ideas and information. 
 
Positive Reinforcement 
Positive reinforcement is essential in developing and sustaining good habits (Elder et 
al., 1999). Participants are continually given positive reinforcement from their team 
leaders, as well as each other during the course of the program.  This is done in 
response to feedback about meals cooked at home and exercise activities the 
participants engaged in.  In particular the re-testing which is conducted at the end of the 
program gives participants feedback on the changes they have made.  These results 
offer a practical measurement of improvements and success during the course of the 
program.  Finally, all participants who finish the group attend a graduation ceremony 
where, once again, the positive results they have achieved are celebrated by the group. 
 
Alumni 
Once participants graduate from the program they are invited to be a part of the CHIP 
Alumni which aims to help participants maintain their focus on living a healthy lifestyle.  
The ability to be able to seek continual support from other participants and leaders as 
they make lifelong changes can have a significant impact on their success.   
 
Whilst the results of this program indicate success in improving the health of 
participants in many areas, further research is required to ascertain the long term 
effectiveness.  No studies have been done yet to determine whether or not participants 
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have continued applying the knowledge that they were taught after the program 
concluded.   
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Chapter Five 
Results 
Sample 
The sample consisted of 284 participants with a mean age of 59.17 years and a 
standard deviation of 11.19 years.  65.1% of this population were female (185) and 
34.9% were male (99).  The age distribution for each gender is illustrated in Figure 1.0. 
 
Figure 1.0 The distribution of participants ages for both males and females. 
 
The marital status of the participants is shown below in Figure 2.0:  5.6% were single, 
79.6 were married, 4.9% were divorced and 4.9% were widowed.  
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Figure 2.0 The distribution of the participants marital status.   
 
Of the participants 9.2% reported a previous family history of cardiovascular disease 
mortality, and 3.2% a family history of diabetes myelitis, 2.1% had a previous history of 
stroke, 0.7% a previous history of heart failure and 3.5% a history of bypass.   
 
Change in Biometrics 
Combined Data 
The mean absolute and percentage changes from baseline to post intervention in the 
selected biometrics (weight, body mass index, systolic blood pressure, diastolic blood 
pressure, total cholesterol, low density lipoprotein, high density lipoprotein, triglycerides, 
fasting plasma glucose) were calculated (Table 1).  The distribution of these changes 
for each biometric was tested for normality.  The change distribution for all the 
respective biometrics were found to be either normal or near normal.  Paired t-tests 
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were then calculated for each of the respective biometrics to determine if the changes 
were statistically significant.  
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Table 1: Mean changes in selected chronic diseases risk factors (biometrics) from baseline to post-intervention.  
Factor N** 
Baseline 
Mean  (SD)* 
Post-
intervention 
Mean  (SD)* 
Mean 
Change % Change t statistic p value Cohen’s d 
Weight (kg)  284 88.29  18.78 84.50 17.77 -3.78 -4.21 28.64 <0.001 0.207 
Body mass index (kg/m2) 284 31.86 6.36 30.51 6.10 -1.35 -4.22 30.48 <0.001 0.216 
Systolic blood pressure (mmHg) 284 131.93 14.72 124.85 13.10 -7.08 -4.86 9.78 <0.001 0.508 
Diastolic blood pressure (mmHg) 284 77.24 10.94 73.20 10.45 -4.04 -4.38 6.72 <0.001 0.377 
Total cholesterol (mmol/L) 284 5.30 1.09 4.32 1.00 -.96 -18.09 25.62 <0.001 0.936 
Low density lipoprotein (mmol/L) 284 3.30 .96 2.53 .86 -.77 -22.79 23.23 <0.001 0.844 
High density lipoprotein (mmol/L) 284 1.29 .33 1.17 .28 -.13 -8.66 12.40 <0.001 0.392 
Triglycerides (mmol/L) 284 1.55 .81 1.38 .65 -.17 -4.60 4.65 <0.001 0.231 
Fasting plasma glucose (mmol/L) 284 5.96 1.62 5.48 .96 -.48 -5.67 6.44 <0.001 0.360 
 
*SD – Standard deviation. **N – Number of participants
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There was statistically significant lowering of all the biometric risk factors with the 
greatest change in low density lipoprotein (22.79%) and total cholesterol (18.09%) 
(Table 1).  Even though the weight change was significant at the .001 level it was the 
smallest percentage change (4.21%) of the biometrics measured and even so is still 
clinically significant.  This lower change is probably due to the short time period of the 
intervention and there is normally a time lag between change of lifestyle patterns and 
weight change.   
The effect size of the change for each biometric was determined using Cohen’s d; 
where values around 0.2 indicate a small change, values around 0.5 indicate a 
moderate change and values around 0.8 indicate a large change.  Both total cholesterol 
and low density lipoprotein recorded a large change with Cohen’s d values of 0.936 and 
0.844 respectively.  Systolic and diastolic blood pressure, high density lipoprotein, and 
fasting plasma glucose recorded moderate changes with Cohen’s d values of 0.508, 
0.377, 0.397, 0.360, whilst weight, body mass index and triglycerides recorded a small 
change in Cohen’s d values of 0.216 and 0.231.  
The lifestyle intervention program resulted in significant reductions across all the 
biometric risk factors measured: weight, body mass index, systolic blood pressure, 
diastolic blood pressure, total cholesterol, low density lipoprotein, high density 
lipoprotein, triglycerides and fasting plasma glucose. These reductions were greatest for 
low density lipoprotein and total cholesterol.  The reduction recorded for weight, body 
mass index and triglycerides were small comparative to the changes in the other risk 
factors, however, they were still significant at the 0.001 level. 
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These results indicate that these Hawera volunteer-delivered 30 day CHIP based 
lifestyle intervention programs were effective in reducing biometrics and thus lowering 
the potential risk of cardiovascular disease.   
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Stratified Data 
The biometric data was further analysed by first stratifying the data for each biometric in 
terms of initial risk condition categories, using ‘The National Cholesterol Education 
Program Adult Treatment Panel III, 2002’ convention or the Framingham Classification.  
Each participant’s initial (baseline) reading for the respective biometric groups was 
categorised according to this convention, from lowest to highest risk (Table 2).  Body 
mass index was divided into 3 risk categories: 18.5 - 24.9 kg/m2, 25 – 30 kg/m2 and >30 
kg/m2.  Systolic Blood Pressure was divided into 4 risk categories:  <120, 120-139, 140-
160 and >160.  Diastolic Blood Pressure was divided into 4 risk categories: <80, 80-89, 
90-100 and >100.  Total Cholesterol was divided into 5 risk categories:  <4.00, 4.00-
5.20, 5.21-5.99, 6.00-6.99 and >7.00.  Low density lipoprotein was divided into 4 risk 
categories:  <2.50, 2.50-2.99, 3.00-4.00 and >4.00. High density lipoprotein was divided 
into 3 risk categories:  <1.00, 1.00-1.55, >1.55.  Triglycerides were divided into 3 risk 
categories:  <1.00, 1.00-2.25 and >2.25.  Finally fasting plasma glucose was also 
divided into 3 risk categories:  <5.60, 5.60-7.00 and >7.00. 
For each risk category across all the biometrics, a paired t-test was performed to 
determine whether there was a significant reduction in the post intervention results due 
to the lifestyle change.  Initially the percentage change (reduction or increase) for each 
risk category across all biometrics were calculated and then for each change the effect 
size was estimated using Cohen’s d (Table 2). The percentage of the sample within 
each risk category was calculated for baseline and post intervention to enable an 
analysis of the change in risk category numbers due to the lifestyle education 
intervention.
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Table 2: Changes in chronic disease risk factor levels within 30 days according to initial risk factor classification.  
Risk Factor 
N 
Baseline 
N  
Post-
intervention 
Baseline  
Mean  (SD) 
Post-intervention  
Mean  (SD) 
Mean  
Change 
% Mean  
Change p t 
Cohen’s 
d 
Body mass index (kg/m2) 
18.5 - 24.9 33 (11.6%) 42 (15.1%) 23.37 1.23 22.54 1.23 -0.83 -3.55% <0.001 9.458 .674 
25 – 30 93 (32.8%) 108 (38.7%) 27.85 1.42 26.66 1.36 -1.19 -4.27% <.001 21.550 .855 
> 30 157 (54.4%) 129 (46.23%) 36.02 5.44 34.47 5.28 -1.55 -4.30% <.001 23.731 .289 
Systolic blood pressure (mmHg) 
<120 59 (20.77%) 109 (38.38%) 111.69 6.86 113.28 9.57 1.59 1.42% >.208 -1.274 -0.190 
120-139 150 (52.81%) 139 (48.94%) 130.78 4.80 124.57 10.84 -6.21 -4.75% <.001 6.725 0.741 
140-160 70 (24.64%) 34 (11.97%) 148.61 6.52 133.37 11.31 -15.24 -10.25% <.001 12.465 1.651 
>160 5 (1.76%) 2 (.704%) 171.80 10.42 150.4 12.48 -21.4 -12.46% >.005 5.570 1.861 
Diastolic blood pressure (mmHg) 
<80 156 (54.92%) 199 (70.07%) 69.50 7.01 68.13 7.832 -1.37 -1.97% >.876 .156 0.184 
80-89 92 (32.39%) 74 (26.05%) 74.67 2.654 76.51 2.851 1.84 2.46% <0.001 7.221 -0.668 
90-100 31 (10.91%) 11 (3.873%) 92.61 2.89 80.35 13.27 -12.26 -13.23% <.001 5.285 1.2 
>100 5 (1.76%) 0 109.00 4.63 86.60 4.27 -22.4 -20.55% <.001 10.161 .76 
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Risk factor 
N 
Baseline 
N Post 
Intervention 
Baseline 
Mean  (SD) 
Post-intervention 
Mean  (SD) 
Mean 
Change 
% Mean 
Change p t 
Cohen’s 
d 
Total cholesterol (mmol/L) 
< 4.00 25 (8.80%) 102 (35.91%) 3.31 .424 2.83 .577 -0.48 -14.50% <.001 4.633 .948 
4.00–5.20 111 (60.32%) 136 (47.88%) 4.62 .342 3.80 .529 -0.82 -17.75% <.001 18.288 1.840 
5.21–5.99 67 (23.59%) 27 (9.50%) 5.60 .203 4.59 .575 -1.01 -18.0% <.001 14.518 2.342 
6.00–6.99 66 (23.23%) 17 (5.98%) 6.36 .299 5.08 .754 -1.28 -20.12% <.001 13.840 2.231 
>7.00 15 (5.28%) 2 (0.70%) 7.54 .403 6.06 .940 -1.48 -19.63% <.001 7.266 2.047 
Low density lipoprotein (mmol/L) 
<2.50 64 (22.53%) 152 (53.52%) 2.04 .493 1.57 .520 -0.48 -23.03% <.001 9.795 0.928 
2.50-2.99 47 (16.55%) 54 (19.01%) 2.80 .144 2.21 .383 -0.59 -21.07% <.001 9.739 2.039 
3.00-4.00 104 (36.61%) 64 (22.53%) 3.47 .290 2.67 .512 -.08 -23.05% <.001 16.860 1.923 
>4.00 69 (24.29%) 14 (4.92%) 4.539 .415 3.44 .702 -1.099 -24.21% <.001 13.566 1.906 
High density lipoprotein (mmol/L) 
<1.00 56 (19.71%) 87 (30.63%) .874 .907 .860 .115 -0.14 -1.60% .33 .977 0.021 
1.00-1.55 162 (57.04%) 169 (59.50%) 1.25 .160 1.14 .179 -.011 -8.8% <.001 10.384 0.648 
>1.55 66 (23.23%) 28 (9.85%) 1.76 .168 1.49 .229 -0.27 -15.34% <.001 10.234 1.344 
39 
 
Risk factor 
N 
Baseline 
N Post 
Intervention 
Baseline 
Mean  (SD) 
Post-intervention 
Mean  (SD) 
Mean 
Change 
% Mean 
Change p t 
Cohen’s 
d 
Triglycerides (mmol/L) 
<1.00 77 (27.11%) 89 (31.33%) .799 .140 .889 .277 0.09 11.56% .001 -3.445 -0.410 
1.00-2.25 162 (57.04%) 172 (66.56%) 1.50 .309 1.40 .503 -0.1 -6.66% .008 2.666 0.239 
>2.25 45 (15.84%) 23 (8.09%) 2.99 .825 2.10 .854 -0.89 -29.76% <.001 6.150 1.059 
Fasting plasma glucose (mmol/L) 
<5.60 147 (51.76%) 194 (68.30%) 5.13 .373 5.07 .377 -0.06 -1.16% .098 1.665 0.159 
5.60-7.00 105 (36.97%) 74 (26.05%) 5.99 .385 5.53 .461 -0.46 -7.68% <.001 10.458 1.083 
>7.00 32 (11.26%) 16 (5.63%) 9.65 2.33 7.17 1.81 -2.48 25.7% <.001 5.016 1.188 
 SD – Standard deviation. 
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There were significant reductions due to the intervention across nearly all the risk 
categories for each of the biometrics studied.  However, participants in the lowest risk 
factor categories for the systolic and diastolic blood pressure, high density lipoprotein 
and fasting plasma glucose biometrics did not register a significant change between the 
baseline and post intervention readings.  For all other categories in these biometrics 
there was a significant change at the 0.05 level.  For body mass index, total cholesterol, 
low density lipoprotein and triglycerides there were significant reductions across all the 
risk factor categories.  
 
With respect to the risk factor levels for each biometric there was a trend in terms of 
percentage change post intervention where the participants in the highest risk factor 
levels most often recorded the greatest percentage reduction.  In general as the 
participants’ risk factor increased, the percentage change in the respective biometrics 
also increased.  However there were some instances where the top two risk factor 
levels recorded similar percentage changes rather than continuing to increase.   
 
For diastolic blood pressure, total cholesterol, low density lipoprotein, triglycerides and 
fasting plasma glucose the percentage change recorded for the highest risk factor level 
ranged from 19 to 29%.  Whereas the percentage change for the lowest risk factor 
levels for most of the biometrics ranged from around 1 to 4%.  
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The size of the pre to post change across the chronic disease baseline risk factor 
levels were analysed using a Cohen’s d.  This calculation was done to ascertain the 
CHIP intervention effect size across these factor levels.  A Cohen’s d effect size of .2 
would be considered small, .5 moderate and >.8 is large. There was a trend across 
the majority of the demographics where the effect size increased as the baseline 
factor levels increased.  There was however a few of the factor groups that had 
slightly different results from the other groups.  The effect size for the change in total 
cholesterol is the greatest across all the initial risk factor levels. Its distribution of 
change across the respective risk factors is different in that the effect size increases 
with each level but peaks at the third level (5.21-5.099) at 2.342 and then starts to 
reduce again.  A possible reasoning for this phenomenon could be that the total 
amount of cholesterol change that can occur in a month has been reached.  Also, 
the last category is unbound (no upper limit) so you have the potential for a very 
large standard deviation and this may impact on the effect size for this category. 
Therefore the continuation of these effects may not be seen over this intervention 
time but may be seen post intervention.   The effect size for BMI is relatively small 
however when compared to the other biometrics.  This is not unexpected as a 
significant weight loss would not normally be recorded within the 30 days.  This could 
be one of the contributing factors to the smaller effect size results for this biometric.  
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Demographic Differences in Biometric Changes 
Introduction 
This section explores the differences in the changes due to the CHIP intervention in 
the respective biometrics across the following demographics:  Gender, Age, Marital 
Status, Family History of Cardiovascular Disease, Family History of Diabetes, Post 
Intervention Exercise Change, Baseline Smoking Status and Baseline Biometrics. 
 
Change in Body Mass Index (BMI)  
Gender 
There was a significant difference between the mean change in BMI for the males (M 
= -1.560, SD = .893) when compared with the females (M = -1.243, SD = .633).  
 [t (282) = -3.468, p = .001]. The male participants recorded a larger mean change 
post intervention compared with the female participants.   
 
Age 
The mean change in BMI values due to CHIP intervention across the various age 
groupings are shown in Table 3.0.  Post hoc tests indicated significance in the 50-59 
and the 60-69 age categories [F (3,283) = 2.717, p <.045].  
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Table 3.0:   Age Change in BMI Values across Age Groups 
Age Group Number Mean Change (M) Standard Deviation (SD) 
20-49 52 1.286 .770 
50-59 80 1.553 .834 
60-69 109 1.281 .701 
70-80+ 43 1.248 .614 
 
The BMI change for the 0-49, 60-69 and 70+ years age groups were similar but the 
50-59 years age group recorded a significantly larger change (Figure 3.0 Age – the 
negative for the mean indicates a reduction in biometric post-intervention). 
 
Figure 3.0:  The Distribution of BMI Change across Age Groups 
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Marital Status 
There were no significant differences in the mean change in BMI across the various 
marital status categories. (Table 3.1 Marital Status) 
Table 3.1:   Change in BMI Values across Marital Status Categories 
Marital Status Mean (M) Standard Deviation (SD) 
Single -1.22 .702 
Married -1.37 .783 
Divorced -1.67 .493 
Widowed -1.14 .444 
 
Family History of Cardiovascular Disease 
There was a significant difference between the mean change in BMI for those with 
(M = .-1.695, SD = 1.025) or without (M = -1.319, SD = .721) a family history of 
cardiovascular disease.  Post hoc tests indicated that those participants with a family 
history of cardiovascular disease had a greater mean change than those with no 
family history.  [t (246) = -2.397, p <.017] 
Family History of Diabetes 
There was no significant differences between the mean change in BMI for those with 
(M = -1.330, SD = .889) or without (M = -1.344, SD = .756) a family history of 
diabetes.  
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Baseline Exercise Levels 
The mean change in BMI values due to CHIP intervention across the various 
baseline exercise levels are shown in Table 3.2 Baseline Exercise Levels. Analysis 
indicated that there were significant differences in the mean change in BMI across 
baseline exercise categories [F (3,279) = 4.415, p <.005].  
 
Table 3.2:  Change in BMI Values across Baseline Exercise Levels 
 
Exercise Level Mean (M) Standard Deviation (SD) 
None -1.55 .780 
Mild -1.35 .805 
Moderate -1.18 .602 
Vigorous -1.00 .512 
 
The higher the participants’ exercise level at baseline the less change that was 
recorded post intervention (Figure 3.1 Exercise Level).
 
Figure 3.1The Distribution of BMI Change across Baseline Exercise Levels 
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Post Intervention Exercise Change 
The mean change in BMI values due to CHIP intervention across the various post 
intervention levels are shown in Table 3.3 Post Intervention Exercise Levels. 
Analysis indicated that there were significant differences in the mean change in BMI 
across post intervention exercise categories [F (3,275) = 4.332, p <.005].   
Table 3.3:  Change in BMI Values across Post Intervention Exercise Levels 
Exercise Level Number Mean (M) Standard Deviation (SD) 
-3 28 -1.576 .692 
-2 95 -1.508 .716 
-1 105 -1.217 .840 
0 48 -1.181 .513 
 
As the participants increased their levels of exercise from baseline, their reduction in 
BMI increased (Figure 3.2). 
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Figure 3.2:  The Distribution of BMI Change across Post Intervention Exercise Levels 
Baseline Smoking Status 
The mean change in BMI values due to CHIP intervention across the various 
smoking status categories are shown in Table 3.4 Smoking Status.  There were no 
significant differences in the mean change in BMI across the various baseline 
smoking status categories. 
Table 3.4:  Change in BMI Values across Baseline Smoking Status 
Smoking Status Mean (M) Standard Deviation (SD) 
Non-Smoker -1.31 .693 
Ex-Smoker -1.36 .728 
Smoker -1.27 .800 
Live with Heavy Smoker -1.92 1.507 
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Baseline Biometric (BMI) 
The mean change in BMI values due to CHIP intervention across the baseline BMI 
risk level categories are shown in Table 3.5 Baseline BMI.  Analysis indicated that 
there were significant differences in the mean change in BMI across the various BMI 
risk level categories [F (2,283) = 17.655, p <.001]. 
Table 3.5:  Change in BMI Values across Baseline Biometric 
Baseline BMI Number Mean (M) Standard Deviation (SD) 
Normal (18.5 – 24.9kg/m2) 33 -.8317 .505 
Overweight (25-30kg/m2) 93 -1.1914 .533 
Obese (>30kg/m2) 157 -1.550 .818 
 
Those participants with the greatest baseline BMI reading reported the greatest 
lowering of their BMI post intervention (Figure 3.3). 
 
Figure 3.3:   The Distribution of BMI Change across Baseline BMI 
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When comparing the change in BMI levels (post intervention) across the various 
demographics, there were 7 areas where a significant difference was recorded; 
gender, age, family cardiovascular history, baseline biometrics, exercise level 1 and 
exercise change. The male participants recorded a higher level of change to their 
BMI than the female participants.  The age categories of 50-59 and 60-69 recorded a 
greater change then the other age groupings for their BMI.  Those participants with a 
family history of cardiovascular disease recorded a greater change in their BMI post 
intervention than those without a family history.  Those participants with the greatest 
baseline BMI reading reported the greatest lowering of their BMI post intervention. 
Those participants who had a baseline exercise level of none and had increased 
their physical activity to moderate or vigorous during the intervention recorded the 
most significant lowering of the BMI score post intervention.  
 
Change in Blood Pressure Systolic (BP SYS)  
Gender 
There was no significant differences between the mean change in BP SYS for the 
males (M = 8.21, SD = 12.229) when compared with the females (M = .721, SD = 
.530).   
Age 
There were no significant differences in the mean change in BP SYS across the 
various age groupings. (Table 4.0) 
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Table 4.0:  Change in BPSYS Values across Age Groups 
 
Age Group Mean (M) Standard Deviation (SD) 
20-29 .75 6.397 
30-39 3.25 12.174 
40-49 5.81 11.664 
50-59 8.20 12.168 
60-69 8.39 11.383 
70-79 3.44 15.551 
80+ 8.00 10.124 
 
Marital Status 
There were no significant differences in the mean change in BP SYS across the 
various marital status categories. (Table 4.1) 
 
Table 4.1:  Change in BPSYS Values across Marital Status Groups 
 
Marital Status Mean (M) Standard Deviation (SD) 
Single 7.50 9.805 
Married 7.60 12.246 
Divorced 5.36 10.609 
Widowed 1.36 13.659 
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Family History of Cardiovascular Disease 
There was no significant differences between the mean change in BP SYS for those 
with (M = 9.19, SD = 15.922) or without (M = 7.10, SD = 11.927) a family history of 
cardiovascular disease.  
Family History of Diabetes 
There was no significant differences between the mean change in BP SYS for those 
with (M = 13.00, SD = 14.500) or without (M = 7.13, SD = 12.283) a family history of 
diabetes.  
Baseline Exercise Levels 
There were no significant differences in the mean change in BP SYS across the 
various baseline exercise categories. (Table 4.2) 
Table 4.2:  Change in BPSYS Values across Baseline Exercise Levels 
 
Exercise Level Mean (M) Standard Deviation (SD) 
None 6.69 11.830 
Mild 6.43 13.614 
Moderate 7.70 11.056 
Vigorous 6.50 9.477 
 
Post Intervention Exercise Change 
There were no significant differences in the mean change in BP SYS across the 
various post intervention exercise change levels. (Table 4.3) 
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Table 4.3:  Change in BPSYS Values across Post Intervention Exercise Levels 
 
Exercise Level Number Mean (M) Standard Deviation (SD) 
-3 28 2.21 12.621 
-2 95 7.40 11.911 
-1 105 6.55 12.120 
0 48 7.94 11.566 
1 1 24.00  
2 1 31.00  
 
Baseline Smoking Status 
There were no significant differences in the mean change in BP SYS across the 
various baseline smoking status categories. (Table 4.4) 
Table 4.4:  Change in BPSYS Values across Baseline Smoking Status Categories 
 
Smoking Status Mean (M) Standard Deviation (SD) 
Non-Smoker 6.46 11.775 
Ex-Smoker 7.30 13.752 
Smoker 7.00 11.874 
Live with Heavy Smoker 9.78 13.944 
 
Baseline Biometric:  BP SYS 
The mean change in BP SYS values due to CHIP intervention across the baseline 
BP SYS risk level categories are shown in Table 4.5.  Analysis indicated that there 
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were significant differences in the mean change in BP SYS across the various BP 
SYS risk level categories [F (3,284) = 29.962, p <.001]. 
Table 4.5:  Change in BPSYS Values across Baseline Biometric 
 
Baseline BP SYS Number Mean (M) Standard Deviation (SD) 
<120 59 -1.59 9.603 
120.1 - 139 150 6.21 11.304 
140-160 70 15.24 10.231 
>160 5 21.40 8.591 
 
Those participants with the greatest baseline BP SYS reading reported the greatest 
lowering of their BP SYS levels post intervention. (Figure 4.0) 
 
Figure 4.0:   The Distribution of BP SYS Change across Baseline BP SYS 
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When comparing the change in BP SYS (post intervention) across the various 
demographics, only the baseline BP SYS registered a significant difference.  In this 
situation those participants with the greatest BP SYS pressure reading reported the 
greatest lowering of their BP SYS levels post intervention.   
 
Change in Blood Pressure Diastolic (BP DIA)  
Gender 
There was no significant differences between the mean change in BP DIA for the 
males (M = 4.161, SD = 9.909) when compared with the females (M = 3.968, SD = 
10.265).   
Age 
There were no significant differences in the mean change in BP DIA across the 
various age groupings. (Table 5.0) 
Table 5.0:  Change in BP DIA Values across Age Groups 
 
Age Group Mean (M) Standard Deviation (SD) 
20-29 -1.500 6.806 
30-39 4.666 11.452 
40-49 4.361 11.151 
50-59 3.225 10.434 
60-69 4.779 9.978 
70-79 2.558 9.468 
80+ 8.111 6.153 
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Marital Status 
There were no significant differences in the mean change in BP DIA across the 
various marital status categories. (Table 5.1) 
 
Table 5.1:  Change in BP DIA Values across Marital Status Categories 
 
Marital Status Mean (M) Standard Deviation (SD) 
Single 3.875 8.898 
Married 4.508 10.479 
Divorced 1.785 5.767 
Widowed 1.214 8.059 
 
Family History of Cardiovascular Disease 
There was no significant differences between the mean change in BP DIA for those 
with (M = 4.846, SD = 10.212) or without (M = 4.301, SD = 10.261) a family history of 
cardiovascular disease.  
Family History of Diabetes 
There was no significant differences between the mean change in BP DIA for those 
with (M = 5.667, SD = 9.797) or without (M = 4.426, SD = 10.260) a family history of 
diabetes.  
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Baseline Exercise Levels 
There were no significant differences in the mean change in BP DIA across the 
various baseline exercise categories. (Table 5.2) 
Table 5.2:  Change in BP DIA Values across Baseline Exercise Levels 
 
Exercise Level Mean (M) Standard Deviation (SD) 
None 3.814 10.805 
Mild 4.096 10.582 
Moderate 3.963 9.214 
Vigorous 3.285 8.597 
 
Post Intervention Exercise Change 
There were no significant differences in the mean change in BP DIA across the 
various post intervention exercise change levels. (Table 5.3) 
 
Table 5.3:  Change in BP DIA Values across Post Intervention Exercise Change Levels 
 
Exercise Level Number Mean (M) Standard Deviation (SD) 
-3 28 .714 10.366 
-2 95 3.652 9.250 
-1 105 4.295 10.616 
0 50 5.5400 10.167 
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Baseline Smoking Status 
There were no significant differences in the mean change in BP DIA across the 
various baseline smoking status categories. (Table 5.4) 
 
Table 5.4:  Change in BP DIA Values across Baseline Smoking Status Levels 
 
Smoking Status Mean (M) Standard Deviation (SD) 
Non-Smoker 3.689 9.757 
Ex-Smoker 3.787 11.001 
Smoker 10.333 15.612 
Live with Heavy Smoker 3.888 6.972 
 
Baseline Biometric: BP DIA 
The mean change in BP DIA values due to CHIP intervention across the baseline BP 
DIA risk level categories are shown in Table 5.5.  Analysis indicated that there were 
significant differences in the mean change in BP DIA across the various BP DIA risk 
level categories [F (3,284) = 29.574, p <.001]. 
Table 5.5:  Change in BP DIA Values across Baseline Biometric 
 
Baseline BP DIA Number Mean (M) Standard Deviation (SD) 
Normal <80 156 .096 7.700 
Pre-hypertensive 80-89 92 6.945 9.226 
High 90-100 31 12.258 12.915 
Dangerous >100 5 22.400 4.929 
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Those participants with the greatest BP DIA pressure reading reported the greatest 
lowering of their BP DIA levels post intervention. (Figure 5.0) 
 
Figure 5.0:   The Distribution of BP DIA Change across Baseline BP DIA 
When comparing the change in BP DIA (post intervention) across the various 
demographics, only the baseline BP DIA registered a significant difference.  In this 
situation those participants with the highest BP DIA readings reported the greatest 
lowering of their BP DIA levels post intervention.   
 
Change in Total Cholesterol (All values given in mmol/L) 
Gender 
There was no significant differences between the mean change in total cholesterol 
for the males (M = 1.074, SD = .680) when compared with the females (M = .922, SD 
= .615).   
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Age 
There were no significant differences in the mean change in total cholesterol across 
the various age groupings. (Table 6.0) 
Table 6.0:  Change in Total Cholesterol Values across Age Groups 
 
Age Group Mean (M) Standard Deviation (SD) 
20-29 1.025 .512 
30-39 1.008 .918 
40-49 .863 .613 
50-59 1.132 .665 
60-69 .9606 .616 
70-79 .850 .562 
80+ .622 .589 
 
Marital Status 
There were no significant differences in the mean change in total cholesterol across 
the various marital status categories. (Table 6.1) 
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Table 6.1:  Change in Total Cholesterol Values across Marital Status 
Marital Status Mean (M) Standard Deviation (SD) 
Single .800 .419 
Married .976 .637 
Divorced 1.092 .719 
Widowed .871 .785 
 
Family History of Cardiovascular Disease 
There was no significant differences between the mean change in total cholesterol 
for those with (M = 1.038, SD = .485) or without (M = .949, SD = .640) a family 
history of cardiovascular disease.  
Family History of Diabetes 
There was no significant differences between the mean change in total cholesterol 
for those with (M = .566, SD = .447) or without (M = .967, SD = .630) a family history 
of diabetes.  
Baseline Exercise Level 
There were no significant differences in the mean change in total cholesterol across 
the various baseline exercise categories. (Table 6.2) 
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Table 6.2:  Change in Total Cholesterol Values across Baseline Exercise Levels 
Exercise Level Mean (M) Standard Deviation (SD) 
None .987 .710 
Mild .903 .601 
Moderate 1.050 .648 
Vigorous .965 .552 
 
Post Intervention Exercise Level Change 
There were no significant differences in the mean change in total cholesterol across 
the various post intervention exercise change levels. (Table 6.3) 
Table 6.3:  Change in Total Cholesterol Values across Post Intervention Exercise Levels 
Exercise Level Number Mean (M) Standard Deviation (SD) 
-3 28 1.000 .673 
-2 95 1.018 .598 
-1 105 .949 .633 
0 48 .918 .745 
1 1 2.100  
 
Baseline Smoking Status 
There were no significant differences in the mean change in total cholesterol across 
the various baseline smoking status categories. (Table 6.4) 
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Table 6.4:  Change in Total Cholesterol Values across Baseline Smoking Status 
Smoking Status Mean (M) Standard Deviation (SD) 
Non-Smoker .993 .617 
Ex-Smoker .977 .729 
Smoker .644 .477 
Live with Heavy Smoker .911 .645 
 
Baseline Total Cholesterol 
The mean change in Total Cholesterol values due to CHIP intervention across the 
baseline Total Cholesterol risk level categories are shown in Table 6.5.  Analysis 
indicated that there were significant differences in the mean change in Total 
Cholesterol across the various Total Cholesterol risk level categories [F (4,279) = 
13.494, p <.001]. 
Table 6.5:  Change in Total Cholesterol Values across Baseline Biometric 
Baseline Total Cholesterol Number Mean (M) Standard Deviation (SD) 
Optimal <4.00 25 .480 .518 
Elevated (4.00-5.20) 111 .819 .472 
High (5.21-5.99) 67 1.004 .566 
Very High (6-6.99) 66 1.281 .752 
Dangerous (>7.00) 15 1.480 .789 
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Those participants with the greatest baseline cholesterol reading reported the 
greatest lowering of their total cholesterol levels post intervention.  (Figure 6.0) 
 
 
Figure 6.0:   The Distribution of Total Cholesterol Change across Baseline Total Cholesterol 
When comparing the change in total cholesterol (post intervention) across the 
various demographics, only the baseline total cholesterol registered a significant 
difference.  In this situation those participants with the greatest baseline cholesterol 
reading reported the greatest lowering of their total cholesterol levels post 
intervention.   
Change in Low Density Lipoprotein (LDL) (mmol/L) 
Gender 
There was no significant differences between the mean change in LDL for the males 
(M = .847, SD = .592) when compared with the females (M = .721, SD = .530).   
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Age 
The mean change in LDL values due to CHIP intervention across the various age 
groupings are shown in Table 7.0.  Post hoc tests indicated significance in the 40-59 
and the 50-59 age categories [F (6,283) = 2.211, p <.042]. 
 
Table 7.0:  Change in LDL Values across Age Groups  
Age Group Mean (M) Standard Deviation (SD) 
20-29 .675 .221 
30-39 .866 .697 
40-49 .583 .599 
50-59 .918 .553 
60-69 .747 .538 
70-79 .691 .472 
80+ .522 .530 
 
The LDL change for the 0-49 and 70+ years age groups were similar but the 50-59 
years age group recorded a significantly larger change (Figure 7.0). 
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Figure 7.0:   The Distribution of LDL Change across Age Categories 
Marital Status 
There were no significant differences in the mean change in LDL across the various 
marital status categories. (Table 7.1) 
Table 7.1:  Change in LDL Values across Marital Status Groups 
Marital Status Mean (M) Standard Deviation (SD) 
Single .593 .399 
Married .756 .555 
Divorced .978 .615 
Widowed .678 .635 
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Family History of Cardiovascular Disease 
There was no significant differences between the mean change in LDL for those with 
(M = .780, SD = .342) or without (M = .745, SD = .563) a family history of 
cardiovascular disease.  
Family History of Diabetes 
There was no significant differences between the mean change in LDL for those with 
(M = .411, SD = .325) or without (M = .756, SD = .549) a family history of diabetes.  
Baseline Exercise Levels 
There were no significant differences in the mean change in LDL across the various 
baseline exercise categories. (Table 7.2) 
Table 7.2:  Change in LDL Values across Baseline Exercise Levels 
Exercise Level Mean (M) Standard Deviation (SD) 
None .770 .634 
Mild .717 .512 
Moderate .822 .549 
Vigorous .750 .478 
 
Post Intervention Exercise Change 
There were no significant differences in the mean change in LDL across the various 
post intervention exercise change levels. (Table 7.3) 
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Table 7.3:  Change in LDL Values across Post Intervention Exercise Levels  
Exercise Level Number Mean (M) Standard Deviation (SD) 
-3 28 .757 .655 
-2 95 .792 .521 
-1 105 .762 .525 
0 48 .718 .634 
1 1 1.900  
2 1 .600  
 
Baseline Smoking Status 
There were no significant differences in the mean change in LDL across the various 
baseline smoking status categories. (Table 7.4) 
Table 7.4:  Change in LDL Values across Baseline Smoking Status 
Smoking Status Mean (M) Standard Deviation (SD) 
Non-Smoker .785 .557 
Ex-Smoker .768 .599 
Smoker .400 .316 
Live with Heavy Smoker .700 .264 
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Baseline Biometric: LDL 
The mean changes in LDL values due to CHIP intervention across the baseline LDL 
risk level categories are shown in Table 7.5.  Analysis indicated that there were 
significant differences in the mean change in LDL across the various LDL risk level 
categories [F (3,283) = 19.054, p <.001]. 
Table 7.5:  Change in LDL Values across Baseline Biometric  
Baseline LDL Number Mean (M) Standard Deviation (SD) 
Optimal <2.5 64 .475 .387 
Elevated 2.50-3.00 47 .583 .410 
High 3.00-4.00 104 .804 .486 
Very High >4.00 69 1.098 .672 
 
Those participants with the greatest baseline LDL reading reported the greatest 
lowering of their LDL levels post intervention. (Figure 7.1)
 
Figure 7.1:   The Distribution of LDL Change across Baseline LDL 
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When comparing the change in LDL levels (post intervention) across the various 
demographics, only the baseline LDL and the 40-40 – 50-59 age categories 
registered a significant difference.  In this situation those participants with the 
greatest baseline LDL reading reported the greatest lowering of their LDL levels post 
intervention.   
 
Change in High Density Lipoprotein (HDL) (mmol/L) 
Gender 
There was a significant difference between the mean change in HDL for the males 
(M = .0928, SD = .140) when compared with the females (M = .147, SD = .187). The 
female participants recorded a greater mean change in their high density lipoprotein 
levels [t (282) = -2.536, p <.012]. 
Age 
There were no significant differences in the mean change in HDL across the various 
age groupings (Table 8.0). 
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Table 8.0:  Change in HDL Values across Age Groups 
Age Group Mean (M) Standard Deviation (SD) 
20-29 .170 .161 
30-39 .060 .176 
40-49 .136 .192 
50-59 .162 .197 
60-69 .115 .156 
70-79 .120 .144 
80+ .052 .182 
 
Marital Status 
There were no significant differences in the mean change in HDL across the various 
marital status categories. (Table 8.1) 
Table 8.1:  Change in HDL Values across Marital Status Groups 
Marital Status Mean (M) Standard Deviation (SD) 
Single .197 .196 
Married .118 .178 
Divorced .143 .165 
Widowed .162 .130 
 
  
71 
 
Family History of Cardiovascular Disease 
There was no significant differences between the mean change in HDL for those with 
(M = .130, SD = .201) or without (M = .122, SD = .174) a family history of 
cardiovascular disease.  
Family History of Diabetes 
There was no significant differences between the mean change in HDL for those with 
(M = .083, SD = .213) or without (M = .123, SD = .174) a family history of diabetes.  
Baseline Exercise Levels 
There were no significant differences in the mean change in HDL across the various 
baseline exercise levels. (Table 8.2) 
Table 8.2:  Change in HDL Values across Baseline Exercise levels 
Exercise Level Mean (M) Standard Deviation (SD) 
None .109 .194 
Mild .117 .159 
Moderate .152 .170 
Vigorous .139 .178 
 
Post Intervention Exercise Change 
There were no significant differences in the mean change in HDL across the various 
post intervention exercise change levels. (Table 8.3) 
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Table 8.3:  Change in HDL Values across Post Intervention Exercise Levels 
Exercise Level Number Mean (M) Standard Deviation (SD) 
-3 28 .122 .161 
-2 95 .126 .168 
-1 105 .127 .186 
0 48 .133 .172 
1 1 -0.050  
2 1 .190  
 
Baseline Smoking Status 
There were no significant differences in the mean change in HDL across the various 
baseline smoking status categories. (Table 8.4) 
Table 8.4:  Change in HDL Values across Baseline Smoking Status 
Smoking Status Mean (M) Standard Deviation (SD) 
Non-Smoker .128 .153 
Ex-Smoker .143 .198 
Smoker -.035 .180 
Live with Heavy Smoker .124 .333 
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Baseline Biometric:  HDL 
The mean changes in HDL values due to CHIP intervention across the baseline HDL 
risk level categories are shown in Table 8.5.  Analysis indicated that there were 
significant differences in the mean change in HDL across the various HDL risk level 
categories [F (2, 284) = 43.517, p <.001]. 
Table 8.5:  Change in HDL Values across Baseline Biometric 
Baseline HDL Number Mean (M) Standard Deviation (SD) 
<1.00 56 .014 .109 
1.00 – 1.55 162 .111 .136 
>1.55 66 .266 .211 
 
Those participants with the greatest baseline HDL reading reported the greatest 
lowering of their HDL levels post intervention.  (Figure 8.0) 
 
Figure 8.0:   The Distribution of HDL Change across Baseline HDL 
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When comparing the change in HDL levels (post intervention) across the various 
demographics, only the baseline HDL, and gender categories registered a significant 
difference.  In this situation those participants with the greatest baseline HDL reading 
reported the greatest lowering of their HDL levels post intervention.  The female 
participants also recorded a greater change than the male participants with their HDL 
levels.   
Change in Triglycerides (TRIG) 
Gender 
There was a significant difference between the mean change in TRIG for the males 
(M = .295, SD = .575) when compared with the females (M = .100, SD = .619).  [t 
(282) = 2.591, p <.010]. The change in mean for males was greater than the females 
post intervention.   
Age 
There were no significant differences in the mean change in TRIG across the various 
age groupings. (Table 9.0) 
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Table 9.0:  Change in TRIG Values across Age Groups 
Age Group Mean (M) Standard Deviation (SD) 
20-29 .397 1.405 
30-39 .182 .718 
40-49 .240 .950 
50-59 .105 .581 
60-69 .207 .472 
70-79 .098 .539 
80+ .114 .280 
 
Marital Status 
There were no significant differences in the mean change in TRIG across the various 
marital status categories (Table 9.1). 
Table 9.1:  Change in TRIG Values across Marital Status Groups 
Marital Status Mean (M) Standard Deviation (SD) 
Single .002 .528 
Married .212 .633 
Divorced -.092 .464 
Widowed .055 .434 
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Family History of Cardiovascular Disease 
There was no significant differences between the mean change in TRIG for those 
with (M = .274, SD = .458) or without (M = .164, SD = .652) a family history of 
cardiovascular disease.  
Family History of Diabetes 
There was no significant differences between the mean change in TRIG for those 
with (M = -.166, SD = .653) or without (M = .188, SD = .635) a family history of 
diabetes.  
Baseline Exercise Levels 
There were no significant differences in the mean change in TRIG across the various 
baseline exercise categories (Table 9.2). 
Table 9.2:  Change in TRIG Values across Baseline Exercise Levels 
Exercise Level Mean (M) Standard Deviation (SD) 
None .208 .754 
Mild .158 .554 
Moderate .137 .579 
Vigorous .144 .239 
 
Post Intervention Exercise Change 
There were no significant differences in the mean change in TRIG across the various 
post intervention exercise change levels (Table 9.3). 
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Table 9.3:  Change in TRIG Values across Post Intervention Exercise Levels 
Exercise Level Number Mean (M) Standard Deviation (SD) 
-3 28 .262 1.017 
-2 95 .233 .562 
-1 105 .086 .558 
0 48 .151 .514 
1 1 .540  
2 1 -.020  
 
Baseline Smoking Status 
There were no significant differences in the mean change in TRIG across the various 
baseline smoking status categories. (Table 9.4) 
Table 9.4:  Change in TRIG Values across Baseline Smoking Status 
Smoking Status Mean (M) Standard Deviation (SD) 
Non-Smoker .159 .610 
Ex-Smoker .137 .587 
Smoker .588 .799 
Live with Heavy Smoker .192 .604 
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Baseline Biometric: TRIG 
The mean changes in TRIG values due to CHIP intervention across the baseline 
TRIG risk level categories are shown in Table 9.5.  Analysis indicated that there 
were significant differences in the mean change in TRIG across the various TRIG 
risk level categories [F (2,284) = 54.561, p <.001]. 
Table 9.5:  Change in TRIG Values across Baseline Biometric 
Baseline TRIG Number Mean (M) Standard Deviation (SD) 
Optimal <1.00 77 -.091 .230 
Above Optimal 1.00-2.24 162 .091 .434 
High >2.25 45 .888 .969 
 
Those participants with the greatest baseline TRIG reading reported the greatest 
lowering of their TRIG levels post intervention. (Figure 9.0) 
 
Figure 9.0:   The Distribution of HDL Change across Baseline HDL 
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When comparing the change in TRIG levels (post intervention) across the various 
demographics, only the baseline TRIG and gender registered a significant difference.  
In this situation those participants with the greatest baseline t TRIG reading reported 
the greatest lowering of their TRIG levels post intervention.  The male participants 
also scored a greater lowering of their TRIG levels post intervention than the female 
participants.   
Change in Glucose  
Gender 
There was no significant differences between the mean change in glucose for the 
males (M = .674, SD = 1.681) when compared with the females (M = .391, SD = 
.952).   
Age 
There were no significant differences in the mean change in glucose across the 
various age groupings. (Table 10.0) 
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Table 10.0:  Change in Glucose Values across Age Groups 
Age Group Mean (M) Standard Deviation (SD) 
20-29 .050 .129 
30-39 .241 .394 
40-49 .455 1.184 
50-59 .702 1.769 
60-69 .445 1.073 
70-79 .320 .718 
80+ .166 .430 
 
Marital Status 
The mean changes in Glucose values due to CHIP intervention across the marital 
status categories are shown in Table 10.1.  Analysis indicated that there were 
significant differences in the mean change in Glucose for the divorced marital status 
only [F (3,270) = 6.498, p <.000]. 
Table 10.1:  Change in Glucose Values across Marital Status Groups 
Marital Status Mean (M) Standard Deviation (SD) 
Single .012 .364 
Married .440 .960 
Divorced 1.750 3.615 
Widowed .135 .501 
 
81 
 
Those participants who identified as being divorced had a greater mean change in 
their glucose level post intervention than the other marital status categories. (Figure 
10.0) 
 
Figure 10.0:   The Distribution of Glucose Change across Marital Status Groups 
 
Family History of Cardiovascular Disease 
There was no significant differences between the mean change in glucose for those 
with (M = .407, SD = .545) or without (M = .550, SD = 1.388) a family history of 
cardiovascular disease.  
Family History of Diabetes 
There was no significant differences between the mean change in glucose for those 
with (M = .422, SD = .578) or without (M = .545, SD = 1.357) a family history of 
diabetes.  
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Baseline Exercise Levels 
There were no significant differences in the mean change in glucose across the 
various baseline exercise categories. (Table 10.2) 
Table 10.2:  Change in Glucose Values across Baseline Exercise Levels 
Exercise Level Mean (M) Standard Deviation (SD) 
None .493 .785 
Mild .601 1.852 
Moderate .343 .665 
Vigorous .392 .695 
 
Post Intervention Exercise Change 
There were no significant differences in the mean change in glucose across the 
various post intervention exercise change levels. (Table 10.3) 
Table 10.3:  Change in Glucose Values across Post Intervention Exercise Levels 
Exercise Level Number Mean (M) Standard Deviation (SD) 
-3 28 .417 .734 
-2 95 .469 1.093 
-1 105 .582 1.688 
0 48 .322 .659 
1 1 .200  
2 1 .600  
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Baseline Smoking Status 
There were no significant differences in the mean change in glucose across the 
various baseline smoking status categories. (Table 10.4) 
Table 10.4:  Change in Glucose Values across Baseline Smoking Status 
Smoking Status Mean (M) Standard Deviation (SD) 
Non-Smoker .423 .801 
Ex-Smoker .565 1.989 
Smoker .555 1.303 
Live with Heavy Smoker .522 .473 
 
Baseline Biometric:  Glucose 
The mean changes in Glucose values due to CHIP intervention across the baseline 
Glucose risk level categories are shown in Table 10.5.  Analysis indicated that there 
were significant differences in the mean change in Glucose across the various 
baseline Glucose categories [F (2,284) = 73.384, p <.001]. 
Table 10.5:  Change in Glucose Values across Baseline Biometric 
Baseline Glucose Number Mean (M) Standard Deviation (SD) 
<5.6 147 .063 .460 
5.6-7 105 .456 .446 
>7 32 2.481 2.798 
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Those participants with the greatest baseline glucose reading reported the greatest 
lowering of their glucose levels post intervention. (Figure 10.1) 
 
Figure 10.1:   The Distribution of Glucose Change across Baseline Glucose 
When comparing the change in glucose levels (post intervention) across the various 
demographics, only the baseline glucose level and those participants with a divorced 
marital status registered a significant difference.  In this situation those participants 
with the greatest baseline glucose reading reported the greatest lowering of their 
glucose levels post intervention.  In addition, those participants with a divorced 
marital status had the greatest lowering of their glucose levels compared with the 
rest of the participants.   
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Chapter Six 
Discussion of Results 
The blood screening results of the Coronary Health Improvement Program (CHIP) 
conducted in Hawera after the 30 days indicated considerable improvement in 
participants biometrics overall. The chronic disease risk factors from baseline to 
post-intervention all recorded improvement; from 4% (weight, BMI, systolic blood 
pressure, diastolic blood pressure) to 23 % (low density lipoprotein).  In particular a 
minimum of 20% improvement was recorded for those participants who were in the 
highest classification groups of total cholesterol (20%), LDL (24%), triglycerides 
(30%) and glucose (26%).  
Each of the chronic disease risk factors excluding total cholesterol were further 
divided into risk factor levels according to the guidelines specified in The National 
Cholesterol Education Program Adult Treatment Panel III classification system.  
Total cholesterol was divided into 5 levels according to the Framingham study.  
These risk factor levels provided a more descriptive analysis to be conducted to 
analyse the movement of participants through the levels from baseline to post 
intervention.   
One of the effects of the 30 day intervention was to reduce the number of 
participants classified in the higher risk factor levels. Out of 284 participants, 173 
(60.9%) were classified in the top two risk factor levels for LDL.  This figure 
decreased by 33.5% to 78 participants post intervention. Participants that were 
categorised in the top two levels for total cholesterol at baseline comprised of 28.5% 
of the total participants.  Remarkably this percentage decreased to just 6.68% post 
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intervention giving an overall decrease of 28.8%. Whilst LDL and total cholesterol 
recorded the most significant decreases in the percentage of participants in these 
risk factor levels; reductions were recorded for the other biometrics.  Participants 
decreased by 16.5% in the highest factor levels for fasting plasma glucose.   BPSYS 
showed a decrease of 13.7%, HDL (10.9%), BPDIA (8.8%), TRIG (7.7%) and finally 
BMI had a decrease of (2.5%).   
All biometric changes when compared with the baseline figures recorded a 
significant difference.  However, participants with the highest baseline risk levels 
recorded the greatest lowering of these levels post intervention.   
Of the demographic factors studied, only gender, age and marital status had a 
statistically significant impact on the change in some post intervention biometrics. 
Regarding the impact of gender on the biometrics, male participants recorded a 
higher level of change for their BMI score and triglyceride levels than the female 
participants. However the female participants recorded a greater change to their 
HDL levels than the males. The age group of 50-59 and 60-69 recorded a greater 
change than the other age groupings for their BMI whereas the 40-49 and 50-59 age 
categories recorded greater change in the LDL levels than the other age groups.   
For glucose levels, those participants with a divorced marital status recorded a 
higher change then participants from all the other marital status categories.   
 
It is evident from the results above that CHIP conducted in Hawera was effective in 
reducing the cardiovascular disease risk factors for participants.  However it is also 
important to understand the significance of these results when they are compared 
with other programs.   
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The overall mean change percentages of the biometrics in this case study was 
compared to the results of the study of the CHIP programs which were conducted in 
America (Rankin et al., 2012).  The results of this community based program study 
were comparable biometric reductions (BMI, BPDia, LDL and HDL) or better 
reductions BMI had a 3.22% greater reduction, BPDia 0.18%, LDL 5.79% and HDL 
3.96% than the American study (Rankin et al., 2012).  These results indicate the 
success of the Hawera based volunteer-delivered community- based CHIP program 
in reducing the probability of developing cardiovascular disease.    
It is difficult to make comparisons between the results of this Hawera case study and 
that of the Ornish Spectrum and Pritikin lifestyle centres in their effectiveness in 
reducing cardiovascular disease for their participants.  Whilst all programs have 
proven to be successful in their own way by reducing cardiovascular disease risk 
factors, the mediums of measurement of change was vastly different and thus 
difficult to draw direct comparisons between the programs.  However it is important 
to note that the results achieved by the CHIP program were accomplished in a 
community based setting with a team of volunteers.  The CHIP program is 
undoubtedly an effective low cost alternative to the more costly residential based 
programs. 
 
This success of this program in reducing cardiovascular disease risk factors can in 
part be attributed to the distinctive delivery of Dr T and his team.  Unlike the 
American programs, which were conducted by a different team of professionals each 
time, the Hawera programs were run under the same leadership.   
 
88 
 
As mentioned previously there are many key elements that are required to conduct a 
successful community education program.  Dr T and his team were proactive in 
delivering a program with a style that would give participants every opportunity to 
succeed in making healthy improvements to their lifestyle.  The program had a 
strong leadership team which was volunteer based, including Dr T who is well 
respected in the community.  In addition, his support team also consisted of previous 
CHIP participants.  The dynamics of this leadership team were a real asset for the 
program delivery.  Firstly, the participants felt they could put their trust in Dr T, and 
they could also relate to those team members who had already completed this 
program.  Another important aspect in the delivery of this program was the focus on 
practical applications for the theory that was being delivered via DVD.  Participants 
were given course material that they were required to complete and discuss as a 
group.  This process facilitated rich learning experiences for participants as they 
were able to reflect and gather new ideas from each other.  Practical cooking 
demonstrations and tastings also gave participants the skills they needed to 
implement healthy eating practices in their own homes.  
Those involved in the CHIP programs in Hawera were self-selecting and their 
willingness to sign up for the program indicated that they were motivated to learn and 
make changes.  Positive reinforcement was given verbally by the leadership team 
throughout the meetings and the final blood screening results enabled participants to 
see the positive improvements they had made to their health in those 30 days.  
Finally, at the conclusion of the program the graduates were invited to join the CHIP 
alumni which would be able to offer support and encouragement long term while 
participants continued their healthy lifestyle journey.   These factors contributed 
significantly to the success of the CHIP program.   
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Whilst this study has aimed to assess the nature and effectiveness of the CHIP 
program in Hawera in reducing cardiovascular disease risk factor it also provides 
opportunity for greater research to be conducted in the area of preventative health. 
A limitation of this study is assessing the results of the program beyond the 30 day 
intervention.  Many questions about the long term success of the program lie in the 
ability to measure the effectiveness of participants in maintaining these lifestyle 
changes in future years.   
Further research should also be done to determine how compliant participants were 
in applying the principles of health that were taught during the program and how 
these compliance levels reflected in the final results.    
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Appendices 
Appendix 1 CHIP Questionnaire  
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CHIP Lifestyle Evaluation 
 
Name: ___________________________________________________ Today’s date: _____________ 
 
Address: __________________________________________________________________________ 
 
Phone (home) ________________  Business/Mobile: _______________________________________ 
 
Occupation: ___________________________    Your doctor: ________________________________ 
 
Age: ____________   Male   Female   Marital status ___________________________________ 
 
One or both parents died before 60: Of heart disease?  Yes  No;  Of diabetes?  Yes   No  
 
Check (X) if you have ever been told by a physician that you have any of the following: 
 
Angina  (Yr)? __________ Abnormal EKG (last 3 
yrs)  
Gall bladder trouble  Ulcers 
Heart attack (yr)? _______ Irregular heartbeats Nervous breakdown Osteoarthritis 
Angioplasty (Yr)? _______ Stroke (Yr)? ________ Kidney disease Rheumatoid arthritis 
Bypass (Yr)? ________ High blood pressure 
highest ever?  ____/____ 
Chronic bronchitis Overweight 
Heart failure (Yr)? ____ High cholesterol Emphysema Gout 
Blood clotting problem High triglycerides Thyroid disorder Diabetes 
 
Please fill in the number of servings you eat or  
drink weekly. If you don’t use, then mark “0”. 
Please fill in every space. 
Meat or shellfish _____ Salad dressings ________ 
Fowl or fish ________ Mayonnaise __________ 
Whole milk or 2% ___ Margarine  ___________ 
Cottage cheese ______ Gravies _____________ 
Butter or cream _____ Soymeat/gluten _______ 
Cheese ____________ Soy milk _____________ 
Sour cream _________ Water _______________ 
Ice cream/ice milk ___ Alcohol _____________ 
Yoghurt ___________ Coffee/tea ___________ 
Liver/organ meats ___ Soft drinks ___________ 
Sausage/hot dogs ____ Sugar or sweets ________ 
Eggs ______________ Sugary desserts ________ 
Fried foods _________ Honey or syrup _______ 
Salty snacks _________ Jam/jelly/custard ______ 
 
 
      
    Recommendation to improve your health based on tests and 
health history: above: 
    Increase daily water to 8-10 glasses 
    Lose weight _____ kg 
    Reduce or eliminate salt 
    Avoid cholesterol intake (meats, sausages, 
     fowl, fish, egg yolks, liver, ice cream, cheese) 
    Reduce all dietary fat 
    Reduce refined sugar in diet 
    Increase aerobic/walking exercise 
    Substitute fruit, vegetables, potatoes for  
        processed, refined foods 
    Stop smoking 
    Eliminate caffeine drinks 
    Increase rest and relaxation 
    Make breakfast a bigger meal 
    See your doctor 
Rest & stress 
Evening is the biggest 
meal 
Eat little or no breakfast
  
6 hrs sleep or 
less/night 
Sleep restlessly 
Suffer insomnia 
   
   
   
   
   
   
   
   
 
 
 
Exercise 
(beyond everyday occupation) 
None 
Mild, at least 4x/wk 
Moderate, at least 
4x/wk 
Vigorous, at least 4x/wk 
 
 
 
   
 
   
    
      
    
   
    
  
OFFICE USE ONLY 
Height _____ Wt. ______ 
Frame: Small 
Medium Large 
Ideal weight ___________ 
Blood pressure ____/____ 
Pulse (resting) _____/min. 
Results of blood test 
  
   
   
Recommended program: 
Weight management 
Stress management 
Stop smoking 
Low cholesterol meal 
management 
Low salt cookery 
Exercise/walking program 
  
 
   
  
